4//SEC Filing
Watts Ryan J. 4
Accession 0001714899-25-000049
CIK 0001714899other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 8:24 PM ET
Size
7.7 KB
Accession
0001714899-25-000049
Insider Transaction Report
Form 4
Watts Ryan J.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-01-07$20.81/sh−7,650$159,197→ 253,071 total - Sale
Common Stock
2025-01-06$20.22/sh−29,266$591,759→ 260,721 total
Holdings
- 2,202,604(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $19.91 to $20.23 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 177,940 Unvested RSUs.
- [F4]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001724310
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 8:24 PM ET
- Size
- 7.7 KB